AFP and hepatocellular carcinoma: In summary, our study showed that the combination of the 4210 Da and 1866 Da polypeptides had better diagnostic value in the occurrence and development of hepatitis B-related chronic hepatitis, liver cirrhosis and hepatocellular carcinoma, especially HCC in alpha-fetoprotein (AFP)-negative patients, than either alone.